Becker's Healthcare April 18, 2024
Researchers are expanding horizons for the diseases and disorders that GLP-1s such as Ozempic, Mounjaro and Wegovy could treat.
As glucagon-like peptide-1 receptor agonists, the therapies mimic a gut hormone that suppresses appetite and promotes a feeling of fullness. The drug class is increasingly popular — especially for off-label prescriptions for weight loss — and ongoing research hints at a larger portfolio of potential uses. Demand for the drugs has soared in recent years and more studies are finding ways it can improve treatment for diseases beyond diabetes and obesity.
Here are nine diseases researchers are exploring using GLP-1s to treat:
1. Sleep apnea
Among adult study participants with moderate to severe obstructive sleep apnea and obesity, about 30 fewer...
Today's Sponsors
Today's Sponsor